Phase II evaluation of thioTEPA for treatment of central nervous system tumors

Cancer Treat Rep. 1979 Aug;63(8):1419-21.

Abstract

Nineteen patients with primary malignant gliomas were treated with thioTEPA. It was found to be ineffective in 13 evaluable patients.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Astrocytoma / drug therapy
  • Brain Neoplasms / drug therapy*
  • Drug Evaluation
  • Glioblastoma / drug therapy
  • Glioma / drug therapy
  • Humans
  • Middle Aged
  • Thiotepa / therapeutic use*

Substances

  • Thiotepa